Cary J. Claiborne - 18 Aug 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Executive Officer
Signature
/s/ Cary J. Claiborne
Issuer symbol
ADIL
Transactions as of
18 Aug 2022
Net transactions value
$0
Form type
4
Filing time
22 Aug 2022, 16:42:53 UTC
Previous filing
28 Jul 2022
Next filing
20 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Award $0 +1,000,000 $0.000000 1,000,000 18 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are Restricted Stock Units that vest monthly pro rata over the next 36 months.